Natco Pharma Ltd

NATCOPHARM
Pharmaceuticals
โ‚น 893.70
Price
โ‚น 16,004
Market Cap
Mid Cap
8.50
P/E Ratio

๐Ÿ“Š Score Snapshot

12.26 / 25
Performance
24.81 / 25
Valuation
4.4 / 20
Growth
7.0 / 30
Profitability
48.48 / 100
Risky

๐Ÿข Company Overview

โณ Loading company overview...

๐Ÿค– CARL Insights

โณ Loading CARL insights...

๐Ÿ“ˆ Net Profit (Yearly)

๐Ÿ“Š Sales (Yearly)

๐Ÿ“‰ Quarterly Sales Trend

๐Ÿ“‰ Quarterly Net Profit

๐Ÿ“ˆ Yearly Ratios

Metric Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Adj Cash EBITDA - 1,573 1,085 88.60 465.10 576.40 919.60 664.30
Adj Cash EBITDA Margin - 42.99 43.66 5.19 21.31 30.97 41.19 33.04
Adj Cash EBITDA To EBITDA - 0.84 1.06 0.28 0.69 0.86 1.01 0.69
Adj Cash EPS - 60.08 43.43 -1.38 13.84 20.66 36.32 22.19
Adj Cash PAT - 1,076 792.63 -25.21 253.49 373.28 661.49 408.14
Adj Cash PAT To PAT - 0.78 1.09 -0.12 0.54 0.79 1.01 0.58
Adj Cash PE - 16.57 13.21 - 67.28 26.00 15.68 35.94
Adj EPS 105.25 77.36 40.00 11.29 25.51 26.02 35.85 38.17
Adj EV To Cash EBITDA - 10.65 8.77 159.01 32.36 16.52 11.04 21.51
Adj EV To EBITDA 4.72 8.90 9.31 44.03 22.20 14.13 11.14 14.90
Adj Number Of Shares 17.91 17.91 18.25 18.26 18.24 18.21 18.27 18.44
Adj PE 7.66 12.88 14.37 81.91 34.83 20.47 15.89 20.70
Adj Peg 0.21 0.14 0.06 - - - - 0.56
Bvps 425.01 326.80 267.01 233.46 226.04 207.80 191.02 166.81
Cash Conversion Cycle 362.00 345.00 394.00 507.00 539.00 395.00 410.00 257.00
Cash ROCE - 16.44 15.69 -5.10 2.91 3.19 8.18 2.53
Cash Roic - 19.03 17.17 -7.23 1.85 1.52 6.35 1.75
Cash Revenue - 3,658 2,485 1,706 2,183 1,861 2,233 2,011
Cash Revenue To Revenue - 0.91 0.92 0.88 1.06 0.97 1.07 0.92
Dio 405.00 357.00 432.00 496.00 570.00 534.00 545.00 389.00
Dpo 145.00 120.00 153.00 105.00 104.00 244.00 224.00 239.00
Dso 103.00 109.00 115.00 116.00 73.00 105.00 88.00 106.00
Dividend Yield 0.78 0.93 0.97 0.58 0.63 1.32 1.13 1.06
EV 12,041 16,744 9,516 14,088 15,050 9,522 10,150 14,289
EV To EBITDA 4.72 8.88 9.48 50.86 23.30 14.47 11.32 15.06
EV To Fcff - 20.42 13.79 - 218.84 175.77 50.63 344.66
Fcfe - 1,104 541.63 -36.21 114.49 56.28 511.49 20.14
Fcfe Margin - 30.19 21.80 -2.12 5.25 3.02 22.91 1.00
Fcfe To Adj PAT - 0.80 0.74 -0.18 0.25 0.12 0.78 0.03
Fcff - 819.96 690.24 -278.57 68.77 54.17 200.46 41.46
Fcff Margin - 22.42 27.78 -16.33 3.15 2.91 8.98 2.06
Fcff To NOPAT - 0.63 1.08 -2.74 0.18 0.14 0.36 0.06
Market Cap 14,417 17,865 10,287 14,186 15,372 9,395 10,215 14,380
PB 1.89 3.05 2.11 3.33 3.73 2.48 2.93 4.68
PE 7.65 12.87 14.39 83.45 34.85 20.38 15.87 20.66
Peg 0.21 0.13 0.04 - - - - 0.58
PS 3.25 4.47 3.80 7.29 7.49 4.91 4.88 6.58
ROCE 26.96 24.96 14.65 3.28 10.07 11.58 18.13 27.30
ROE 27.97 25.83 15.98 4.92 11.80 12.95 19.89 29.72
Roic 33.36 30.15 15.91 2.64 10.03 10.93 17.58 28.54
Share Price 804.95 997.50 563.65 776.90 842.75 515.90 559.10 779.85

๐Ÿ“Š Quarterly Results

Metric Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Sales 1,221 475.00 1,371 1,363 1,068 759.00 1,031 1,140 898.00 492.00 432.00 885.00 597.00 560.00
Interest 10.00 4.00 4.00 5.00 6.00 5.00 4.00 4.00 3.00 4.00 4.00 4.00 7.00 5.00
Expenses - 673.00 436.00 567.00 558.00 571.00 490.00 573.00 612.00 559.00 387.00 337.00 489.00 615.00 459.00
Other Income - 66.00 176.00 64.00 48.00 42.00 37.00 29.00 20.00 29.00 21.00 20.00 34.00 14.00 30.00
Depreciation 98.00 47.00 46.00 44.00 56.00 44.00 44.00 44.00 41.00 42.00 42.00 40.00 38.00 36.00
Profit Before Tax 506.00 164.00 818.00 804.00 478.00 256.00 440.00 500.00 324.00 81.00 70.00 386.00 -50.00 91.00
Tax % 19.76 19.51 17.36 16.92 19.25 16.80 16.14 16.00 14.81 23.46 18.57 17.10 - 12.09
Net Profit - 406.00 132.00 676.00 668.00 386.00 213.00 369.00 420.00 276.00 62.00 57.00 320.00 -50.00 80.00
Minority Share 1.00 1.00 1.00 - - - - - - - - - - -
Profit Excl Exceptional 406.00 132.00 676.00 668.00 386.00 213.00 369.00 420.00 276.00 62.00 57.00 320.00 -50.00 -
Profit For PE 406.00 132.00 676.00 668.00 386.00 213.00 369.00 420.00 276.00 62.00 57.00 320.00 -50.00 80.00
Profit For EPS 407.00 133.00 677.00 668.00 386.00 213.00 369.00 420.00 276.00 62.00 57.00 320.00 -50.00 80.00
EPS In Rs 22.70 7.43 37.81 37.32 21.57 11.88 20.60 23.47 15.11 3.41 3.11 17.55 -2.77 4.41
PAT Margin % 33.25 27.79 49.31 49.01 36.14 28.06 35.79 36.84 30.73 12.60 13.19 36.16 -8.38 14.29
PBT Margin 41.44 34.53 59.66 58.99 44.76 33.73 42.68 43.86 36.08 16.46 16.20 43.62 -8.38 16.25
Tax 100.00 32.00 142.00 136.00 92.00 43.00 71.00 80.00 48.00 19.00 13.00 66.00 - 11.00
Yoy Profit Growth % 5.00 -38.00 83.00 59.00 40.00 241.00 550.00 31.00 646.00 -23.00 -13.00 327.00 -195.00 28.00
Adj Ebit 516.00 168.00 822.00 809.00 483.00 262.00 443.00 504.00 327.00 84.00 73.00 390.00 -42.00 95.00
Adj EBITDA 614.00 215.00 868.00 853.00 539.00 306.00 487.00 548.00 368.00 126.00 115.00 430.00 -4.00 131.00
Adj EBITDA Margin 50.29 45.26 63.31 62.58 50.47 40.32 47.24 48.07 40.98 25.61 26.62 48.59 -0.67 23.39
Adj Ebit Margin 42.26 35.37 59.96 59.35 45.22 34.52 42.97 44.21 36.41 17.07 16.90 44.07 -7.04 16.96
Adj PAT 406.00 132.00 676.00 668.00 386.00 213.00 369.00 420.00 276.00 62.00 57.00 320.00 -50.00 80.00
Adj PAT Margin 33.25 27.79 49.31 49.01 36.14 28.06 35.79 36.84 30.73 12.60 13.19 36.16 -8.38 14.29
Ebit 516.00 168.00 822.00 809.00 483.00 262.00 443.00 504.00 327.00 84.00 73.00 390.00 -42.00 95.00
EBITDA 614.00 215.00 868.00 853.00 539.00 306.00 487.00 548.00 368.00 126.00 115.00 430.00 -4.00 131.00
EBITDA Margin 50.29 45.26 63.31 62.58 50.47 40.32 47.24 48.07 40.98 25.61 26.62 48.59 -0.67 23.39
Ebit Margin 42.26 35.37 59.96 59.35 45.22 34.52 42.97 44.21 36.41 17.07 16.90 44.07 -7.04 16.96
NOPAT 361.08 -6.44 626.41 632.24 356.11 187.20 347.18 406.56 253.87 48.22 43.16 295.12 -56.00 57.14
NOPAT Margin 29.57 -1.36 45.69 46.39 33.34 24.66 33.67 35.66 28.27 9.80 9.99 33.35 -9.38 10.20
Operating Profit 450.00 -8.00 758.00 761.00 441.00 225.00 414.00 484.00 298.00 63.00 53.00 356.00 -56.00 65.00
Operating Profit Margin 36.86 -1.68 55.29 55.83 41.29 29.64 40.16 42.46 33.18 12.80 12.27 40.23 -9.38 11.61

๐Ÿ’ฐ Profit & Loss

Metric Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Mar 2014
Sales 4,430 3,999 2,707 1,945 2,052 1,915 2,094 2,185 2,020 1,042 825.00 739.00
Interest 24.00 19.00 14.00 18.00 13.00 22.00 19.00 15.00 18.00 23.00 32.00 37.00
Expenses - 2,234 2,245 1,772 1,681 1,446 1,332 1,300 1,256 1,337 777.00 615.00 560.00
Other Income - 354.00 128.00 87.00 56.00 72.00 91.00 117.00 30.00 14.00 12.00 15.00 16.00
Exceptional Items - -3.00 18.00 43.00 32.00 16.00 14.00 10.00 - - -15.00 1.00
Depreciation 235.00 187.00 164.00 143.00 117.00 100.00 81.00 66.00 54.00 51.00 47.00 30.00
Profit Before Tax 2,291 1,674 862.00 202.00 580.00 569.00 825.00 887.00 624.00 204.00 132.00 129.00
Tax % 17.81 17.08 17.05 15.84 23.79 19.51 22.18 21.65 22.28 23.53 1.52 24.03
Net Profit - 1,883 1,388 715.00 170.00 442.00 458.00 642.00 695.00 485.00 156.00 130.00 98.00
Minority Share 2.00 - - - -2.00 3.00 2.00 1.00 1.00 1.00 4.00 5.00
Exceptional Items At - -2.00 14.00 33.00 24.00 13.00 10.00 8.00 - - -11.00 1.00
Profit Excl Exceptional 1,883 1,390 701.00 137.00 419.00 446.00 632.00 687.00 485.00 156.00 141.00 97.00
Profit For PE 1,883 1,390 701.00 137.00 417.00 446.00 632.00 687.00 485.00 156.00 141.00 97.00
Profit For EPS 1,885 1,388 715.00 170.00 441.00 461.00 644.00 696.00 486.00 157.00 135.00 103.00
EPS In Rs 105.26 77.51 39.18 9.31 24.18 25.31 35.24 37.74 27.88 9.02 8.10 6.21
Dividend Payout % 6.00 12.00 14.00 48.00 22.00 27.00 18.00 22.00 24.00 14.00 12.00 16.00
PAT Margin % 42.51 34.71 26.41 8.74 21.54 23.92 30.66 31.81 24.01 14.97 15.76 13.26
PBT Margin 51.72 41.86 31.84 10.39 28.27 29.71 39.40 40.59 30.89 19.58 16.00 17.46
Tax 408.00 286.00 147.00 32.00 138.00 111.00 183.00 192.00 139.00 48.00 2.00 31.00
Adj Ebit 2,315 1,695 858.00 177.00 561.00 574.00 830.00 893.00 643.00 226.00 178.00 165.00
Adj EBITDA 2,550 1,882 1,022 320.00 678.00 674.00 911.00 959.00 697.00 277.00 225.00 195.00
Adj EBITDA Margin 57.56 47.06 37.75 16.45 33.04 35.20 43.51 43.89 34.50 26.58 27.27 26.39
Adj Ebit Margin 52.26 42.39 31.70 9.10 27.34 29.97 39.64 40.87 31.83 21.69 21.58 22.33
Adj PAT 1,883 1,386 729.93 206.19 466.39 470.88 652.89 702.84 485.00 156.00 115.23 98.76
Adj PAT Margin 42.51 34.65 26.96 10.60 22.73 24.59 31.18 32.17 24.01 14.97 13.97 13.36
Ebit 2,315 1,698 840.00 134.00 529.00 558.00 816.00 883.00 643.00 226.00 193.00 164.00
EBITDA 2,550 1,885 1,004 277.00 646.00 658.00 897.00 949.00 697.00 277.00 240.00 194.00
EBITDA Margin 57.56 47.14 37.09 14.24 31.48 34.36 42.84 43.43 34.50 26.58 29.09 26.25
Ebit Margin 52.26 42.46 31.03 6.89 25.78 29.14 38.97 40.41 31.83 21.69 23.39 22.19
NOPAT 1,612 1,299 639.54 101.83 372.67 388.77 554.86 676.16 488.86 163.65 160.52 113.20
NOPAT Margin 36.38 32.49 23.63 5.24 18.16 20.30 26.50 30.95 24.20 15.71 19.46 15.32
Operating Profit 1,961 1,567 771.00 121.00 489.00 483.00 713.00 863.00 629.00 214.00 163.00 149.00
Operating Profit Margin 44.27 39.18 28.48 6.22 23.83 25.22 34.05 39.50 31.14 20.54 19.76 20.16

๐Ÿฆ Balance Sheet

Metric Mar 2025 Sep 2024 Mar 2024 Sep 2023 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018
Accumulated Depreciation - - 1,112 - 948.00 815.00 679.00 564.00 467.00 389.00
Advance From Customers - - 85.00 - 86.00 3.00 1.00 - 19.00 18.00
Average Capital Employed 7,058 6,454 5,632 - 4,860 4,536 4,247 3,990 3,564 2,563
Average Invested Capital 4,831 4,693 4,309 - 4,020 3,851 3,716 3,558 3,156 2,369
Average Total Assets 7,768 7,250 6,282 - 5,383 4,950 4,690 4,446 4,009 3,016
Average Total Equity 6,732 6,226 5,363 - 4,568 4,193 3,954 3,637 3,283 2,364
Cwip 225.00 234.00 137.00 84.00 64.00 130.00 223.00 518.00 638.00 480.00
Capital Employed 7,892 7,366 6,224 5,541 5,040 4,679 4,392 4,102 3,877 3,250
Cash Equivalents 2,176 1,562 953.00 720.00 546.00 206.00 284.00 66.00 280.00 184.00
Fixed Assets 2,698 2,541 2,491 2,468 2,427 2,312 2,023 1,584 1,227 1,019
Gross Block - - 3,603 - 3,375 3,127 2,702 2,149 1,694 1,408
Inventory 766.00 775.00 700.00 710.00 743.00 762.00 798.00 558.00 529.00 438.00
Invested Capital 5,051 4,951 4,611 4,435 4,007 4,033 3,669 3,764 3,353 2,958
Investments 474.00 643.00 539.00 387.00 392.00 308.00 304.00 112.00 169.00 76.00
Lease Liabilities 2.00 2.00 8.00 2.00 2.00 12.00 2.00 - - -
Loans N Advances 192.00 209.00 129.00 - 104.00 143.00 148.00 167.00 83.00 36.00
Long Term Borrowings 5.00 5.00 - 6.00 - - - 1.00 - -
Net Debt -2,371 -1,997 -1,121 -859.00 -771.00 -98.00 -320.00 138.00 -63.00 -87.00
Net Working Capital 2,128 2,176 1,983 1,883 1,516 1,591 1,423 1,662 1,488 1,459
Non Controlling Interest 5.00 7.00 - - - - 2.00 11.00 2.00 4.00
Other Asset Items 854.00 844.00 767.00 757.00 524.00 628.00 599.00 1,031 872.00 844.00
Other Borrowings - - - - - - - - - -
Other Liability Items 464.00 565.00 361.00 347.00 267.00 265.00 253.00 231.00 190.00 178.00
Reserves 7,571 7,114 5,817 5,258 4,837 4,227 4,085 3,737 3,452 3,035
Share Capital 36.00 36.00 36.00 36.00 36.00 36.00 36.00 36.00 36.00 37.00
Short Term Borrowings 273.00 201.00 363.00 239.00 165.00 404.00 266.00 315.00 386.00 173.00
Short Term Loans And Advances - - 9.00 9.00 10.00 10.00 13.00 8.00 7.00 4.00
Total Assets 8,631 8,245 6,906 6,254 5,657 5,109 4,792 4,588 4,303 3,715
Total Borrowings 279.00 208.00 371.00 248.00 167.00 416.00 268.00 316.00 386.00 173.00
Total Equity 7,612 7,157 5,853 5,294 4,873 4,263 4,123 3,784 3,490 3,076
Total Equity And Liabilities 8,631 8,245 6,906 6,254 5,657 5,109 4,792 4,588 4,303 3,715
Total Liabilities 1,019 1,088 1,053 960.00 784.00 846.00 669.00 804.00 813.00 639.00
Trade Payables 275.00 314.00 236.00 366.00 264.00 162.00 146.00 255.00 217.00 269.00
Trade Receivables 1,247 1,436 1,189 1,120 856.00 621.00 413.00 551.00 506.00 638.00

๐Ÿ’ต Cash Flows

Metric Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017
Cash From Financing Activity -247.00 -363.00 35.00 -186.00 -251.00 -51.00 651.00 -48.00
Cash From Investing Activity -1,026 -465.00 4.00 -107.00 -175.00 -611.00 -1,116 -299.00
Cash From Operating Activity 1,212 849.00 46.00 299.00 417.00 669.00 464.00 346.00
Cash Paid For Acquisition Of Companies - - -103.00 - - - - -
Cash Paid For Loan Advances - 0.20 3.70 -4.90 -5.50 -2.50 -1.00 -0.70
Cash Paid For Purchase Of Fixed Assets -359.00 -206.00 -243.00 -255.00 -359.00 -462.00 -424.00 -280.00
Cash Paid For Purchase Of Investments -263.00 -126.00 -29.00 -185.00 -67.00 -112.00 -44.00 -29.00
Cash Paid For Repayment Of Borrowings - -239.00 - -48.00 -80.00 - -48.00 -14.00
Cash Received From Borrowings 198.00 - 138.00 - - 213.00 - 123.00
Cash Received From Issue Of Shares - - - - - - 896.00 -
Cash Received From Sale Of Fixed Assets 2.00 30.00 54.00 47.00 22.00 18.00 18.00 -
Cash Received From Sale Of Investments 129.00 15.00 71.00 7.00 120.00 20.00 - 21.00
Change In Inventory 42.40 19.10 56.40 -240.20 -28.90 -90.60 -89.50 8.40
Change In Other Working Capital Items 17.60 163.70 -60.00 11.10 -51.10 14.10 -36.30 -10.40
Change In Payables -28.10 102.00 7.40 -109.50 41.70 -51.20 6.40 -12.90
Change In Receivables -341.30 -222.30 -238.90 130.60 -53.80 138.80 -174.30 -237.40
Change In Working Capital -309.40 62.70 -231.40 -212.90 -97.60 8.60 -294.70 -253.00
Direct Taxes Paid -286.30 -177.50 -48.20 -130.00 -107.80 -178.80 -204.50 -125.80
Dividends Paid -171.00 -100.00 -82.00 -114.00 -154.00 -111.00 -181.00 -141.00
Interest Paid -18.00 -14.00 -17.00 -13.00 -22.00 -19.00 -16.00 -16.00
Interest Received 58.00 49.00 50.00 67.00 87.00 52.00 10.00 8.00
Net Cash Flow -62.00 21.00 85.00 6.00 -8.00 7.00 -2.00 -1.00
Other Cash Financing Items Paid -256.00 -9.00 -4.00 -11.00 5.00 -134.00 - -
Other Cash Investing Items Paid -594.00 -229.00 205.00 210.00 21.00 -128.00 -675.00 -20.00
Profit From Operations 1,807 963.90 326.10 641.70 622.70 839.00 962.80 724.60

๐Ÿงพ Shareholding Pattern

Nse Code Date Promoters Fii Dii Public Others
Natcopharm 2025-03-31 - 17.49 5.64 27.30 0.00
Natcopharm 2024-12-31 - 17.94 5.59 26.88 0.00
Natcopharm 2024-09-30 - 17.51 6.75 26.13 0.00
Natcopharm 2024-06-30 - 17.45 7.86 24.99 0.00
๐Ÿ’ฌ
Stock Chat